Cambridge biotech TRIMTECH Therapeutics, which is harnessing targeted protein degradation for the treatment of neurodegenerative diseases, has closed an oversubscribed $31 million (£25m) seed round ...

Cambridge biotech company Mestag Therapeutics has appointed experienced executive Dr Matthew Sleeman as Chief Scientific Officer. Mestag is harnessing fibroblast immunology for patients with ...

LinkGevity, an AI-driven drug discovery company focused on revolutionising the treatment of ageing, has been awarded an ...

The first resource containing high-resolution DNA sequencing data for over 37,000 children and parents collected over ...

Cambridge-headquartered video game company Jagex says board member Jon Bellamy will succeed Phil Mansell as CEO. Mansell will ...

A new innovation body to harness UK ingenuity and boost military technology is being launched as part of a drive to ...

Airbus has been awarded the UK Ministry of Defence’s Oberon contract to design and build two Synthetic Aperture Radar ...

Babraham Institute Enterprise (BIE) has welcomed four new Non-Executive Directors to its Board. The new Directors are: Dr.

For DeepTech funder Cambridge Innovation Capital, it’s a case of back to the future after its decision to take venture ...

Cambridge company Spotta, which has developed a sustainable solution to tackle the issue of insect pests without relying on ...

Ignota Labs, an AI-driven drug turnaround company which recently moved to Cambridge Science Park, has closed a $6.9 million ...

It’s a win-win for Haverhill Research Park and The Epicentre next door after planners backed what will prove a turnkey ...